Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.87 |
| ▸ | FAAH | O00519 | 4/20 | 0.61 |
| ▸ | CNR1 | P21554 | 2/20 | 0.61 |
| ▸ | CNR2 | P34972 | 2/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.55 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.55 |
| ▸ | ITGAL | P20701 | 3/20 | 0.55 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28341177 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL15649758 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL17203892 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL9664374 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL13279669 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL15650015 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL17204083 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL4348859 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL22034112 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 | |
| SCHEMBL9665932 | 1.00 | SLC6A5 (0.87) | SLC6A5FAAHCNR1CNR2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016094226-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GLYCOREGIMMUNE, INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| US-20160158258-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | ALTIUM GROWTH FUND, LP | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160158258-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | RXRA, RXRG, CX3CR1 | SLC6A5 4866/4885FAAH 452/4885CNR1 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.